SCHEMBL8409371

SCHEMBL8409371

CC(O)(C(=O)Nc1ccc([N+](=O)[O-])cc1Cl)c1ccc([N+](=O)[O-])cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK1 Q15118 4/20 0.57
PDK2 Q15119 4/20 0.57
PDK3 Q15120 4/20 0.57
PDK4 Q16654 4/20 0.57
MAPT P10636 4/20 0.53
ALDH1A1 P00352 2/20 0.53
MEN1 O00255 2/20 0.51
NPC1 O15118 2/20 0.51
MAPK1 P28482 2/20 0.51
RAB9A P51151 2/20 0.51
KMT2A Q03164 2/20 0.51
TRPV1 Q8NER1 1/20 0.51
CYP2C9 P11712 2/20 0.50
CYP2C19 P33261 2/20 0.50
AURKA O14965 1/20 0.50
PDPK1 O15530 1/20 0.50
JAK2 O60674 1/20 0.50
GMNN O75496 1/20 0.50
EGFR P00533 1/20 0.50
LMNA P02545 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4610006 0.83 PDK1 (0.81) PDK1PDK2PDK3PDK4
SCHEMBL6569621 0.83 PDK1 (0.81) PDK1PDK2PDK3PDK4
SCHEMBL8407256 0.82 PDK1 (0.51) PDK1PDK2PDK3PDK4MAPT
SCHEMBL8407302 0.81 MAPT (0.51) PDK1PDK2PDK3PDK4MAPT
SCHEMBL2072672 0.80 MAPT (0.60) PDK1PDK2PDK3PDK4MAPT
SCHEMBL7301679 0.80 HTT (0.71) MAPTALDH1A1MEN1NPC1MAPK1
SCHEMBL8407500 0.79 MAPT (0.50) PDK1PDK2PDK3PDK4MAPT
SCHEMBL8930598 0.78 MAPT (0.63) MAPTALDH1A1MEN1NPC1MAPK1
SCHEMBL10420192 0.77 PDK1 (0.61) PDK1PDK2PDK3PDK4MAPT
SCHEMBL30492664 0.76 MAPT (0.65) MAPTALDH1A1MEN1NPC1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5994362-A ADMINISTERING FINASTERIDE AND CASODEX MERCK & CO., INC. (US) 1999-11-30 US disclosed
EP-0514056-A2 Use of estrogens or antiandrogens for reversal of male sexual phenotype in poultry MERCK & CO. INC. (US) 1992-11-19 EP disclosed
WO-1992016233-A1 PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF PROSTATIC CANCER CONTAINING A 5 ALPHA REDUCTASE INHIBITOR AND AN ANTIANDROGEN MERCK & CO., INC. (US) 1992-10-01 WO disclosed
EP-0040932-B1 AMIDE DERIVATIVES, PROCESS FOR THEIR MANUFACTURE AND PHARMACEUTICAL OR VETERINARY COMPOSITIONS CONTAINING THEM IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1985-07-03 EP disclosed
US-4386080-A 3,4-DISUBSTITUTED-N-ACYLANILINES IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) 1983-05-31 US disclosed
EP-0040932-A1 Amide derivatives, process for their manufacture and pharmaceutical or veterinary compositions containing them IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1981-12-02 EP disclosed